The Mechanism Actions of Astragaloside IV Prevents the Progression of Hypertensive Heart Disease Based on Network Pharmacology and Experimental Pharmacology

The Mechanism Actions of Astragaloside IV Prevents the Progression of Hypertensive Heart Disease Based on Network Pharmacology and Experimental Pharmacology

Astragaloside IV (AS-IV) has been used to treat cardiovascular disease. However, whether AS-IV exerts a protective effect against hypertensive heart disease has not been investigated. This study aimed to investigate the antihypertensive and cardioprotective effects of AS-IV on L-NAME-induced hyperte...

Full description

Bibliographic Details
Main Authors:	Haoran Jing, Rongsheng Xie, Yu Bai, Yuchen Duan, Chongyang Sun, Ye Wang, Rongyi Cao, Zaisheng Ling, Xiufen Qu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Pharmacology
Subjects:	cardiac damage astragaloside IV hypertensive heart disease network pharmacology inflammation antioxidant
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.755653/full

Similar Items

Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
by: Zehui Xu, et al.
Published: (2023-12-01)

Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity
by: Xu J, et al.
Published: (2021-01-01)

Pharmacological Effects of Astragaloside IV: A Review
by: Yutong Liang, et al.
Published: (2023-08-01)

Integrating Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanism of Astragaloside IV in Treating Bleomycin-Induced Pulmonary Fibrosis
by: Yuan S, et al.
Published: (2023-04-01)

In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis
by: Chenliang Ge, et al.
Published: (2020-09-01)

Research progress of astragaloside IV in the treatment of atopic diseases
by: Shencun Yu, et al.
Published: (2022-12-01)

Astragaloside IV, as a potential anticancer agent
by: Dongqin Xia, et al.
Published: (2023-02-01)

Network pharmacology and in vitro experimental verification to reveal the mechanism of Astragaloside IV against kidney ischemia-reperfusion injury
by: Yan Guo, et al.
Published: (2023-11-01)

Identification of Hub Genes in Protective Effect of Astragaloside IV on Aconitine-Induced Cardiac Damage in Zebrafish Based on Bioinformatics Analysis
by: Mingzhu Wang, et al.
Published: (2020-06-01)

A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of Astragaloside IV on intracerebral hemorrhage as an example
by: En Hu, et al.
Published: (2023-04-01)

Astragaloside IV alleviates lipopolysaccharide‐induced preeclampsia‐like phenotypes via suppressing the inflammatory responses
by: Dilihuma Tuerxun, et al.
Published: (2021-03-01)

Calcium Sensing Receptor-Related Pathway Contributes to Cardiac Injury and the Mechanism of Astragaloside IV on Cardioprotection
by: Meili Lu, et al.
Published: (2018-10-01)

Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
by: Lin-Sen Qing, et al.
Published: (2017-07-01)

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
by: Chuang Sun, et al.
Published: (2021-07-01)

Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites
by: Xu-Qin Du, et al.
Published: (2022-05-01)

Astragaloside IV Prevents Cardiac Remodeling in the Apolipoprotein E-Deficient Mice by Regulating Cardiac Homeostasis and Oxidative Stress
by: Xiong-Zhi Li, et al.
Published: (2017-12-01)

Inhibition of miRNA-1-Mediated Inflammation and Autophagy by Astragaloside IV Improves Lipopolysaccharide-Induced Cardiac Dysfunction in Rats
by: Wang Q, et al.
Published: (2022-04-01)

Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
by: Lei Li, et al.
Published: (2023-07-01)

Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress
by: Chunlan Ji, et al.
Published: (2018-09-01)

Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
by: Mei-Ling Xia, et al.
Published: (2020-04-01)

Effect of Astragaloside IV on improving cardiac function in rats with heart failure: a preclinical systematic review and meta-analysis
by: Zhiyuan Zhang, et al.
Published: (2023-10-01)

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
by: Lu-Yun Qin, et al.
Published: (2022-03-01)

Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor
by: Xingkai Liu, et al.
Published: (2022-08-01)

The Effect of Astragaloside IV on Isoproterenol-Induced Myocardial Infarction in Rats
by: Fatemeh Fathizad, et al.
Published: (2019-06-01)

The potential molecular pathways of Astragaloside-IV in colorectal cancer: A systematic review
by: Tang Ziyang, et al.
Published: (2023-11-01)

Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats
by: Feng Zhao, et al.
Published: (2011-05-01)

A Mechanistic Exploratory Study on the Therapeutic Efficacy of Astragaloside IV Against Diabetic Retinopathy Revealed by Network Pharmacology
by: Zhi-Hao Zhao, et al.
Published: (2022-06-01)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
by: Tan YQ, et al.
Published: (2020-09-01)

Ameliorating the Effect of Astragaloside IV on Learning and Memory Deficit after Chronic Cerebral Hypoperfusion in Rats
by: Sooyong Kim, et al.
Published: (2015-01-01)

Astragaloside-IV Alleviates Heat-Induced Inflammation by Inhibiting Endoplasmic Reticulum Stress and Autophagy
by: Zhiwei Dong, et al.
Published: (2017-06-01)

Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis
by: Zhuang Zhuang, et al.
Published: (2019-11-01)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
by: Chunkun Yang, et al.
Published: (2023-05-01)

The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease
by: Yiwei Gao, et al.
Published: (2023-07-01)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
by: Tan J, et al.
Published: (2023-07-01)

Astragaloside IV-enhanced anti-hepatocarcinoma immunity of dendritic cells
by: Hongxing Guo, et al.
Published: (2022-05-01)

Mechanism of Astragaloside Ⅳ on HepG2 Cells Based on Molecular Dynamics Simulation and Experimental Evaluation
by: ZHOU Zhipeng, et al.
Published: (2022-07-01)

Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII
by: Wanting Qin, et al.
Published: (2024-02-01)

The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
by: Li L, et al.
Published: (2023-03-01)

Protective effect of Astragaloside IV against sepsis-induced acute lung injury in rats
by: Ruiqin Huang, et al.
Published: (2016-05-01)

Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
by: Xianhui Kang, et al.
Published: (2021-11-01)